{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:40:09Z","timestamp":1750542009496,"version":"3.41.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>18<\/jats:sup>F-FDG PET\/CT might discover incidental pituitary lesions. We present the case of a 46-year-old woman with breast cancer metastasis in her pituitary. We analyzed 10,347 FDG PET\/CT examinations from a tertiary center, finding 4 cases (0.038%) of pituitary metastatic disease from other cancers. We analyzed the differences between SUVmax in cases of physiological high uptake, primary tumor, and hypophysis metastases from other cancers in our database compared with the literature.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003313","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:16:05Z","timestamp":1602184565000},"page":"e44-e46","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Pituitary Metastases Discovered by 18F-FDG PET\/CT During Other Cancers Monitoring"],"prefix":"10.1097","volume":"46","author":[{"given":"Andra","family":"Piciu","sequence":"first","affiliation":[{"name":"Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Mester","sequence":"additional","affiliation":[{"name":"Oral Health, Iuliu Hatieganu University of Medicine and Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doina","family":"Piciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/jc.2003-030395","article-title":"Tumors metastatic to the pituitary gland: case report and literature review","volume":"89","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/RLU.0b013e31821a26bf","article-title":"Pituitary FDG uptake in a patient of lung cancer with bilateral adrenal metastases causing adrenal cortical insufficiency","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","article-title":"Pituitary tumours: pituitary incidentalomas","volume":"23","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"55544","DOI":"10.18632\/oncotarget.15417","article-title":"Evaluation of pituitary uptake incidentally identified on 18 F-FDG PET\/CT scan","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.110.083733","article-title":"Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00259-010-1571-5","article-title":"Incidental pituitary uptake on whole-body 18F-FDG PET\/CT: a multicentre study","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/RLU.0000000000003101","article-title":"18F-FDG PET\/CT findings in a patient with neurosarcoidosis","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/RLU.0000000000002887","article-title":"FDG PET\/CT findings of ectopic pituitary adenoma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/RLU.0000000000002776","article-title":"FDG PET\/CT image for a Rosai-Dorfman disease with pituitary and bone involvement in a pediatric patient","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1097\/RLU.0000000000002514","article-title":"Therapeutic response to rituximab in IgG4-related hypophysitis evidenced on 18F-FDG PET and MRI","volume":"44","year":"2019","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:05:55Z","timestamp":1750539955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003313"}},"subtitle":["Are There Any Differences of SUVs Between Benign and Malignant Diseases?"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003313","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}